7 results
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... for Preventing ... test should be done ... HumanPapillomavirus #IDSA ... #Prevention #Treatment
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
Guillain-Barre Syndrome ... Pathophysiology ... bradycardia, urinary retention ... Treatment: • Plasmapheresis ... diagnosis #management #treatment
Guillain-Barré Syndrome (GBS)
Acute autoimmune demyelinating polyradiculoneuropathy that presents with rapidly progressive flaccid weakness
Epidemiology:
 • Incidence: 1
Guillain-Barré Syndrome ... surgery, trauma, and bone-marrow ... the underlying pathophysiology ... and cauda equina TREATMENT ... GBS #Guillain #Barre
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... mg PO BID for one ... for effective treatment ... candida #mucosal #IDSA ... #Prevention #Treatment
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
IDSA Recommendations ... 7–10 days • One ... IsosporaBelli #IDSA ... #Prevention #Treatment
Cauda Equina Syndrome Overview

Cauda Equina Syndrome:
 • Prevalence: 1:33,000-100,000 ppl/yr
 • Incidence: 1.5-3.4 million ppl/yr
 •
cord • Guillain-Barre ... bladder for urinary retention ... decreased rectal tone ... axial T1 and T2 Treatment
IDSA Recommendations for Treating Coccidiodomycosis in HIV-AIDS
Treating Mild Infections (Such As Focal Pneumonia or asymptomatic patients
IDSA Recommendations ... BII)* Treating Bone ... Coccidiodomycosis #IDSA ... #Prevention #Treatment